Literature DB >> 24072701

Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis.

Xusen Zhang1, Bailin Zhang, Jidong Gao, Xiang Wang, Zhihua Liu.   

Abstract

MicroRNA (miRNA) 200s regulate E-cadherin by directly targeting ZEB1/ZEB2, which are transcriptional repressors of E-cadherin. Decreased expression of E-cadherin results in cancer cells losing interaction with the extracellular matrix and detaching from the primary tumor. Normally, cells will undergo anoikis after losing interaction with the extracellular matrix. Cancer cells must, therefore, possess the ability to resist anoikis during the process of metastasis. Here we show that miRNA-200b regulates anoikis by directly targeting the 3' UTR of Pin1 mRNA and regulating Pin1 expression at the translational level. We found that down-regulation of miRNA-200b promotes cancer cells survival during metastasis, and the homeless state of these cells resulted in decreased expression of miRNA-200b in the MCF-7 cell line. We also found that expression of miRNA-200b is down-regulated in human breast cancer during lymph node metastasis, which has a significant negative correlation with Pin1 expression. Two members of the ETS (E-26) family (PEA3 and ELK-1) regulate the expression of miRNA-200b. PEA3 promotes the expression of miRNA-200b, and ELK-1 is a transcriptional repressor of miRNA-200b. In addition, miRNA-200b regulates the activity of PEA3 and ELK-1 via the Pin1-pERK pathway and forms self-regulated feedback loops. This study characterizes the role of miRNA-200b in the regulation of anoikis and demonstrates the regulation of its own expression in the process of metastasis.

Entities:  

Keywords:  AKT; Apoptosis; ERK; ETS Family Transcription Factor; MicroRNA

Mesh:

Substances:

Year:  2013        PMID: 24072701      PMCID: PMC3820908          DOI: 10.1074/jbc.M113.478016

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

2.  Role of Pin1 in UVA-induced cell proliferation and malignant transformation in epidermal cells.

Authors:  Chang Yeob Han; Tran Thi Hien; Sung Chul Lim; Keon Wook Kang
Journal:  Biochem Biophys Res Commun       Date:  2011-05-24       Impact factor: 3.575

3.  MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

Authors:  Clemens L Bockmeyer; Matthias Christgen; Mirco Müller; Sebastian Fischer; Philipp Ahrens; Florian Länger; Hans Kreipe; Ulrich Lehmann
Journal:  Breast Cancer Res Treat       Date:  2011-03-17       Impact factor: 4.872

4.  Regulation of vascular endothelial growth factor signaling by miR-200b.

Authors:  Young-Chul Choi; Sena Yoon; Yongsu Jeong; Jaeseung Yoon; Kwanghee Baek
Journal:  Mol Cells       Date:  2011-05-02       Impact factor: 5.034

5.  Smad3 regulates E-cadherin via miRNA-200 pathway.

Authors:  S-M Ahn; J-Y Cha; J Kim; D Kim; H T H Trang; Y-M Kim; Y-H Cho; D Park; S Hong
Journal:  Oncogene       Date:  2011-10-24       Impact factor: 9.867

6.  Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2.

Authors:  Yuk Cheung Chan; Sashwati Roy; Savita Khanna; Chandan K Sen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-12       Impact factor: 8.311

7.  Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.

Authors:  Seogang Hyun; Jung Hyun Lee; Hua Jin; JinWu Nam; Bumjin Namkoong; Gina Lee; Jongkyeong Chung; V Narry Kim
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

8.  Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.

Authors:  Gerburg Wulf; Priti Garg; Yih-Cherng Liou; Dirk Iglehart; Kun Ping Lu
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 9.  PARP-1 activation in the ERK signaling pathway.

Authors:  Malka Cohen-Armon
Journal:  Trends Pharmacol Sci       Date:  2007-10-24       Impact factor: 14.819

10.  MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.

Authors:  Kara McArthur; Biao Feng; Yuexiu Wu; Shali Chen; Subrata Chakrabarti
Journal:  Diabetes       Date:  2011-02-28       Impact factor: 9.461

View more
  24 in total

1.  Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation.

Authors:  Takashi Kawahara; Hiroki Ide; Eiji Kashiwagi; John D Patterson; Satoshi Inoue; Hasanain Khaleel Shareef; Ali Kadhim Aljarah; Yichun Zheng; Alexander S Baras; Hiroshi Miyamoto
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

2.  MicroRNA-150 targets ELK1 and modulates the apoptosis induced by ox-LDL in endothelial cells.

Authors:  Bing Qin; Yaqing Shu; Li Xiao; Tingting Lu; Yinyao Lin; Huan Yang; Zhengqi Lu
Journal:  Mol Cell Biochem       Date:  2017-01-21       Impact factor: 3.396

Review 3.  The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis.

Authors:  Ghader Babaei; Negin Raei; Attabak Toofani Milani; Shiva Gholizadeh-Ghaleh Aziz; Nima Pourjabbar; Faezeh Geravand
Journal:  Mol Biol Rep       Date:  2021-09-12       Impact factor: 2.316

Review 4.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

Review 5.  Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer.

Authors:  Yu Yan; Li-Feng Wang; Rui-Fen Wang
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

Review 6.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

7.  EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.

Authors:  Rui Yang; Xiuxiu Li; Yanan Wu; Guanghui Zhang; Xiaoran Liu; Yanping Li; Yonghua Bao; Wancai Yang; Hongjuan Cui
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

Review 8.  The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.

Authors:  Brock Humphries; Chengfeng Yang
Journal:  Oncotarget       Date:  2015-03-30

9.  Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A.

Authors:  H-C Yu; M-H Hung; Y-L Chen; P-Y Chu; C-Y Wang; T-T Chao; C-Y Liu; C-W Shiau; K-F Chen
Journal:  Cell Death Dis       Date:  2014-07-31       Impact factor: 8.469

Review 10.  Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential.

Authors:  Sharan Malagobadan; Noor Hasima Nagoor
Journal:  Biomed Res Int       Date:  2015-10-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.